IP Library Granted Patent US 8,288,347
Granted Patent B2
US 8,288,347 · App. 12/906,777 · Granted Oct 16, 2012

Dermal fillers comprising silk fibroin hydrogels and uses thereof

Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,288,347
App. No.
12/906,777
Granted
Oct 16, 2012
Kind
B2
Abstract

The present specification provides compositions useful as dermal fillers and methods using such compositions to treat a condition of skin.

Claims (16)

1. A dermal filler composition comprising a gel phase and a carrier phase that increases the fluidity of the gel phase, the gel phase including

a) first hydrogel particles comprising a substantially sericin-depleted silk fibroin; and

b) second hydrogel particles comprising a matrix polymer including an elastic protein;

wherein the first hydrogel particles has a protein structure that makes the hydrogel particles resist biodegradation.

2. The composition of claim 1 , wherein the silk fibroin hydrogel particles comprises about 1% (w/v) to about 10% (w/v) of silk fibroin.

3. The composition of claim 1 , wherein the elastic protein is an elastin.

4. The composition of claim 1 , wherein the silk fibroin hydrogel particles and elastic protein hydrogel particles have a cross-sectional area from about 0.1 μm 2 to about 1000 μm 2 .

5. The composition of claim 1 , wherein the silk fibroin hydrogel particles further comprises an amphiphilic peptide.

6. The composition of claim 1 , wherein the carrier phase is water, a saline solution, or a buffered solution.

7. The composition of claim 1 , wherein the carrier phase further comprises lidocaine.

8. A method of treating a soft tissue condition in an individual in need thereof, the method comprising the step of administering a composition of claim 1 into a skin region of the individual, wherein the administration improves the condition.

9. The method of claim 8 , wherein the soft tissue condition is a breast tissue condition, a facial tissue condition, a neck condition, a skin condition, an upper arm condition, a lower arm condition, a hand condition, a shoulder condition, a back condition, a torso including abdominal condition, a buttock condition, an upper leg condition, a lower leg condition including calf condition, a foot condition including plantar fat pad condition, an eye condition, a genital condition, or a condition effecting another body part, region or area.

10. The method of claim 9 , wherein the breast tissue condition is a breast imperfection, a breast defect, a breast augmentation, or a breast reconstruction.

11. The method of claim 9 , wherein the facial tissue condition is a facial imperfection, a facial defect, a facial augmentation, or a facial reconstruction.

12. The method of claim 9 , wherein the facial tissue condition is a dermal divot, a sunken cheek, a thin lip, a nasal imperfection or defect, a retro-orbital imperfection or defect, a facial fold, a facial line, a facial wrinkle, or other size, shape or contour imperfection or defect of the face.

13. The method of claim 9 , wherein the facial tissue condition is skin dehydration, a lack of skin elasticity, skin roughness, a lack of skin tautness, a skin stretch line or mark, or skin paleness.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2011
From: COLLETTE, ADAM L.; HORAN, REBECCA L.; CHEN, JINGSONG; ALTMAN, GREGORY H.
To: ALLERGAN, INC.
Reel/Frame 025729/0682 →
Continuity (4)
Continuation In Part 12883139 · Sep 15, 2010
Continuation In Part 12764039 · Apr 20, 2010
Provisional Application 61170895 · Apr 20, 2009
Related Publication 20110129531A1 · Jun 2, 2011